You are here

Article Text

Article menu

Download PDFPDF

Miscellaneous
Jaundice in a chronic hepatitis B carrier
  1. R Noun1,
  2. S Zeidan2,
  3. C Ghorra3,
  4. S Slaba4,
  5. L Menassa-Moussa5,
  6. R Sayegh6
  1. 1Saint Joseph University of Beirut, Department of Digestive Surgery, Hotel Dieu de France Hospital, Beirut, Lebanon
  2. 2Department of Digestive Surgery, Hotel Dieu de France Hospital, Beirut, Lebanon
  3. 3Department of Pathology, Hotel Dieu de France Hospital, Beirut, Lebanon
  4. 4Saint Joseph University of Beirut, Department of Radiology, Hotel Dieu de France Hospital, Beirut, Lebanon
  5. 5Department of Radiology, Hotel Dieu de France Hospital, Beirut, Lebanon
  6. 6Saint Joseph University of Beirut, Department of Gastroenterology, Hotel Dieu de France Hospital, Beirut, Lebanon
  1. Correspondence to:
    Dr S Zeidan
    Department of Digestive Surgery, Hotel Dieu de France Hospital, Alfred Naccache Street, Achrafieh, PO Box 166830, Beirut, Lebanon; smart_zeidan{at}yahoo.com

https://doi.org/10.1136/gut.2006.103887

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Clinical presentation

    A 50-year-old man presented with a 4-week history of jaundice that developed progressively. He had chronic hepatitis B. During the last 3 months, he had complained of repetitive bouts of right upper abdominal pain with fever. Clinical examination was normal except for jaundice. Biological tests revealed a normal complete blood count and abnormal liver tests with cholestatic and cytolytic features (γ-glutamyl transpeptidase = 850 IU/l (normal<43 IU/l), alkaline phosphatase = 299 IU/l (normal<126), total bilirubin = 134 μm/l (normal<22), aspartate transaminase = 101 IU/l (normal<59), alanine transaminase = 116 IU/l (normal<72). The α-fetoprotein level was normal and the CA 19-9 level was elevated at 139 IU/ml (normal<37 IU/ml). HBsAg and IgG anti-HBc were positive.

    On abdominal ultrasonography, the intrahepatic bile ducts were dilated. No parenchymal tumour was detected and the gallbladder was unremarkable. Magnetic resonance cholangiopancreatography showed a homogeneous liver parenchyma and a filling defect of the hepatic duct with upward dilatation. Endoscopic retrograde cholangiography was carried out and is shown in fig 1.

    Figure 1
    Figure 1

     Cholangiogram through the ERCP catheter inserted into the common bile duct up to the junction with the cystic duct.There is aneurysmal dilation of the main hepatic duct containing a filling defect with dilated right intrahepatic ducts. The left intrahepatic duct is not visualised.

    Question

    What is the diagnosis and management?

    See page 1425 for answer

    View Abstract

    Footnotes

    • Robin Spiller, Editor

    Linked Articles

    • Miscellaneous
      EDITOR’S QUIZ: GI SNAPSHOT
      BMJ Publishing Group Ltd and British Society of Gastroenterology
      Gut 2007; 56 1425-1425 Published Online First: 13 Sep 2007. doi: 10.1136/gut.2006.103887a